Isodicentric duplication of Philadelphia chromosome as a mechanism of resistance to dasatinib in a patient with chronic myeloid leukemia after resistance to imatinib

被引：3
|
作者：
Loglisci, Giuseppina [1 ]
Breccia, Massimo [1 ]
Nanni, Mauro [1 ]
Mancini, Marco [1 ]
De Cuia, Rosa [1 ]
Cannella, Laura [1 ]
Salaroli, Adriano [1 ]
Federico, Vincenzo [1 ]
Serrao, Alessandra [1 ]
Loglisci, Maria Giovanna [1 ]
Santopietro, Michelina [1 ]
Alimena, Giuliana [1 ]
机构：
[1] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy
来源：
LEUKEMIA & LYMPHOMA | 2011年 / 52卷 / 07期
关键词：
BCR-ABL; GENE AMPLIFICATION; EXPRESSION; MESYLATE; THERAPY; ST1571; CELLS;
D O I：
10.3109/10428194.2011.565394
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1372 / 1375
页数：4
相关论文
共 50 条
  • [1] Dasatinib overcomes imatinib and nilotinib failure in Philadelphia chromosome positive chronic myeloid leukemia with different mechanisms of resistance
    Cannella, Laura
    Breccia, Massimo
    Stefanizzi, Caterina
    Napoleone, Laura
    Santopietro, Michela
    Alimena, Giuliana
    LEUKEMIA & LYMPHOMA, 2009, 50 (05) : 848 - 850
  • [2] Double Philadelphia-chromosome: a resistance factor on the imatinib mesylate therapy for chronic myeloid leukemia
    Otero, L.
    Ornellas, M. H.
    Dobbin, J.
    Fernandez, T. de Souza
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2008, 30 (04) : 346 - 348
  • [3] Dasatinib Early Intervention After Cytogenetic or Hematologic Resistance to Imatinib in Patients With Chronic Myeloid Leukemia
    Quintas-Cardama, Alfonso
    Cortes, Jorge E.
    O'Brien, Susan
    Ravandi, Farhad
    Borthakur, Gautam
    Liu, David
    Bleickardt, Eric
    Chen, Tai-Tsang
    Kantarjian, Hagop M.
    CANCER, 2009, 115 (13) : 2912 - 2921
  • [4] Severe thrombocytopenia after dasatinib treatment in a patient with Philadelphia chromosome-positive chronic myeloid leukemia
    Chen, Runzhe
    Wang, Fei
    Zhang, Xiaoping
    Gao, Chong
    Chen, Baoan
    OncoTargets and Therapy, 2015, 8 : 955 - 957
  • [5] ISODICENTRIC PHILADELPHIA-CHROMOSOME IN ACCELERATED PHASE OF CHRONIC MYELOID-LEUKEMIA
    PERNICE, F
    SQUADRITO, G
    SAITTA, A
    MAZZA, G
    MUSOLINO, C
    CANCER GENETICS AND CYTOGENETICS, 1993, 66 (02) : 113 - 116
  • [6] Duplication of the Ph-chromosome as a possible mechanism of resistance to imatinib mesylate in patients with chronic myelogenous leukemia
    Ossard-Receveur, A
    Bernheim, A
    Clausse, B
    Danglot, G
    Fauvet, D
    Leon, B
    Lozach, F
    Bories, D
    Brouzes, C
    Bourhis, JH
    Turhan, AG
    CANCER GENETICS AND CYTOGENETICS, 2005, 163 (02) : 189 - 190
  • [7] Treatment selection after imatinib resistance in chronic myeloid leukemia
    Elias Jabbour
    Jorge Cortes
    Hagop Kantarjian
    Targeted Oncology, 2009, 4 : 3 - 10
  • [8] Treatment selection after imatinib resistance in chronic myeloid leukemia
    Jabbour, Elias
    Cortes, Jorge
    Kantarjian, Hagop
    TARGETED ONCOLOGY, 2009, 4 (01) : 3 - 10
  • [9] Isodicentric Philadelphia chromosome: an uncommon chromosomal abnormality in the chronic phase of chronic myeloid leukemia (CML)
    Loo, Eric
    Bansal, Pranshu
    Cherukuri, Durga
    Arana Yi, Cecilia
    CLINICAL CASE REPORTS, 2016, 4 (01): : 43 - 45
  • [10] Dasatinib - In chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
    Keam, Susan J.
    BIODRUGS, 2008, 22 (01) : 59 - 69
12345